Advertisement

Urolithiasis

, Volume 45, Issue 3, pp 279–283 | Cite as

The value of hypercalciuria in patients with osteopenia versus osteoporosis

  • María Sierra Girón-Prieto
  • María del Carmen Cano-García
  • Antonio Poyatos-Andújar
  • Salvador Arias-Santiago
  • Tomás de Haro-Muñoz
  • Miguel Arrabal-Martín
  • Miguel Ángel Arrabal-PoloEmail author
Original Paper
  • 198 Downloads

Abstract

The aim of this study was to analyze the presence of lithogenic metabolic factors in the blood and urine of patients with osteopenia versus osteoporosis. This is a cross-sectional study including 67 patients who were divided into two groups according to the presence of either osteopenia or osteoporosis as measured by bone densitometry: group 1—40 patients with osteopenia (22 men and 18 women) and group 2—27 patients with osteoporosis (13 men and 14 women). Metabolic studies were performed on the blood and urine; statistical analysis was performed comparing means and conducting linear correlation and multivariate analyses with SPSS. Statistical significance was considered to be p ≤ 0.05. The mean age of patients in group 1 was 52.9 ± 12.8 years versus 50.3 ± 11.4 in group 2; the difference was not statistically significant. In group 2, higher levels of osteocalcin, β-crosslaps, urinary calcium, fasting urine calcium/creatinine, 24 h urine calcium/creatinine and 24 h oxaluria were observed compared to group 1. In the multivariate analysis, only the β-crosslaps and urinary calcium were independently associated with osteoporosis. It would be advisable to determine the urinary calcium levels in patients with osteoporosis since altered levels may necessitate modifying the diagnostic and therapeutic approach to osteoporosis.

Keywords

Osteopenia Osteoporosis Bone markers Calciuria 

Notes

Acknowledgments

This article is a part of doctoral thesis by Maria Sierra Girón-Prieto in the Doctorado of Medicina Clinica and Salud Publica. Granada University. This investigation has been funded by Fundacion Progreso y Salud. Consejeria de Salud. Junta de Andalucia. Pi 0766/2013.

Compliance with ethical standards

Ethical statement

It is a low ethically responsible study in which the patients gave their informed consent after reading the Patient Information Sheet. The study was approved by the Hospital Ethics Committee.

Conflict of interest

The authors have no conflicts of interest to report.

References

  1. 1.
    Olszynski WP, Shawn Davison K, Adachi JD, Brown JP, Cummings SR, Hanley DA, Harris SP, Hodsman AB, Kendler D, McClung MR, Miller PD, Yuen CK (2004) Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment. Clin Ther 26:15–28CrossRefPubMedGoogle Scholar
  2. 2.
    Gielen E, Vanderschueren D, Callewaert F, Boonen S (2011) Osteoporosis in men. Best Pract Res Clin Endocrinol Metab. 25:321–335CrossRefPubMedGoogle Scholar
  3. 3.
    Painter SE, Kleerekoper M, Camacho PM (2006) Secondary osteoporosis: a review of the recent evidence. Endocr Pract. 12:436–445CrossRefPubMedGoogle Scholar
  4. 4.
    Hudec SM, Camacho PM (2013) Secondary causes of osteoporosis. Endocr Pract 19:120–128CrossRefPubMedGoogle Scholar
  5. 5.
    Polymeris A, Michalakis K, Sarantopoulou V (2013) Secondary osteoporosis—an endocrinological approach focusing on underlying mechanisms. Endocr Regul. 47:137–148CrossRefPubMedGoogle Scholar
  6. 6.
    Arrabal Martín M, Fernández Rodríguez A, Arrabal Polo MA, Ruíz García MJ, Zuluaga Gómez A (2006) Study of the physical-chemical factors in patients with renal lithiasis. Arch Esp Urol 59:583–594PubMedGoogle Scholar
  7. 7.
    Audran M, Legrand E (2000) Hypercalciuria. Joint Bone Spine. 67:509–515CrossRefPubMedGoogle Scholar
  8. 8.
    Arrabal-Polo MA, del Carmen Cano-García M, Canales BK, Arrabal-Martín M (2014) Calcium nephrolithiasis and bone demineralization: pathophysiology, diagnosis, and medical management. Curr Opin Urol 24:633–638CrossRefPubMedGoogle Scholar
  9. 9.
    Zerwekh JE (2010) Bone disease and hypercalciuria in children. Pediatr Nephrol 25:395–401CrossRefPubMedGoogle Scholar
  10. 10.
    Skalova S, Palicka V, Kutilek S (2005) Bone mineral density and urinary N-acetyl-beta-D-glucosaminidase activity in paediatric patients with idiopathic hypercalciuria. Nephrology (Carlton) 10:99–102CrossRefGoogle Scholar
  11. 11.
    Penido MG, Lima EM, Marino VS, Tupinambá AL, França A, Souto MF (2003) Bone alterations in children with idiopathic hypercalciuria at the time of diagnosis. Pediatr Nephrol 18:133–139PubMedGoogle Scholar
  12. 12.
    Ryan LE, Ing SW (2012) Idiopathic hypercalciuria and bone health. Curr Osteoporos Rep. 10:286–295CrossRefPubMedGoogle Scholar
  13. 13.
    Bilić-Curcić I, Milas-Ahić J, Smolić M, Smolić R, Mihaljević I, Tucak-Zorić S (2009) Urolithiasis and osteoporosis: clinical relevance and therapeutic implications. Coll Antropol. 33(Suppl 2):189–192PubMedGoogle Scholar
  14. 14.
    Ryan CS, Petkov VI, Adler RA (2011) Osteoporosis in men: the value of laboratory testing. Osteoporos Int 22:1845–1853CrossRefPubMedGoogle Scholar
  15. 15.
    Cerdà D, Peris P, Monegal A, Albaladejo C, Martínez de Osaba MJ, Surís X, Guañabens N (2011) Increase of PTH in post-menopausal osteoporosis. Rev Clin Esp 211:338–343CrossRefPubMedGoogle Scholar
  16. 16.
    Peris P, Ruiz-Esquide V, Monegal A, Alvarez L, Martínez de Osaba MJ, Martínez-Ferrer A, Reyes R, Guañabens N (2008) Idiopathic osteoporosis in premenopausal women. Clinical characteristics and bone remodelling abnormalities. Clin Exp Rheumatol 26:986–991PubMedGoogle Scholar
  17. 17.
    Odabasi E, Turan M, Tekbas F, Kutlu M (2009) Evaluation of secondary causes that may lead to bone loss in women with osteoporosis: a retrospective study. Arch Gynecol Obstet 279:863–867CrossRefPubMedGoogle Scholar
  18. 18.
    Carvalho M, Kulak CA, Borba VZ (2012) Prevalence of hypercalciuria in postmenopausal women with osteoporosis. Arq Bras Endocrinol Metabol. 56:1–5CrossRefPubMedGoogle Scholar
  19. 19.
    Odvina CV, Poindexter JR, Peterson RD, Zerwekh JE, Pak CY (2008) Intestinal hyperabsorption of calcium and low bone turnover in hypercalciuric postmenopausal osteoporosis. Urol Res 36:233–239CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • María Sierra Girón-Prieto
    • 1
  • María del Carmen Cano-García
    • 2
  • Antonio Poyatos-Andújar
    • 3
  • Salvador Arias-Santiago
    • 4
  • Tomás de Haro-Muñoz
    • 5
  • Miguel Arrabal-Martín
    • 6
  • Miguel Ángel Arrabal-Polo
    • 2
    Email author
  1. 1.Atención Primaria, Granada, Programa de doctorado de medicina clínica y salud públicaUniversidad de GranadaGranadaSpain
  2. 2.UGC Urología intercentrosHospital La InmaculadaAlmeriaSpain
  3. 3.UGC Análisis ClínicosHospital Santa AnaGranadaSpain
  4. 4.Departamento de MedicinaUniversidad de GranadaGranadaSpain
  5. 5.UGC Análisis Clínicos intercentrosHospital Universitario GranadaGranadaSpain
  6. 6.UGC Urología intercentrosHospital Universitario GranadaGranadaSpain

Personalised recommendations